Health officials said they doubt they will need to resort to “human challenge” experiments and Anthony Fauci, MD, head of the National Institute of Allergy and Infectious Diseases, said it would be “plan C or plan D” in vaccine development.
“You generally do this if you don’t have enough infections in the community at any given time to get a signal from the vaccine. Unfortunately for us, we don’t have that problem — we have a lot of infections,” Dr. Fauci told the Post.
If traditional vaccine development methods succeed, the government will not have to use the engineered strain of the coronavirus, the Post reported.
The process of developing a strain of a virus is time-consuming, so traditional methods will likely yield results sooner, according to the Post.
More articles on pharmacy:
Louisiana pharmacy CEO pleads guilty to $50M reimbursement fraud
FDA won’t let Henry Ford use hydroxychloroquine for COVID-19 patients
Pharmacy expansion into primary care could be good for patient satisfaction, survey shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
